Cleared Traditional

K902226 - MY-O-MATIC 5000I

K902226 is an FDA 510(k) clearance for MY-O-MATIC 5000I, manufactured by Monad Corp.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 385-day FDA review.

K902226 · Monad Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1991
Decision
385d
Days
Class 2
Risk

K902226 is an FDA 510(k) clearance for the MY-O-MATIC 5000I. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Monad Corp. (Pomona, US). The FDA issued a Cleared decision on June 6, 1991 after a review of 385 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Monad Corp. devices

FDA 510(k) Submission Details - K902226

510(k) Number K902226 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 1990
Decision Date June 06, 1991
Days to Decision 385 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
237d slower than avg
Panel avg: 148d · This submission: 385d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 287
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K902226.
TEAM-MC
K905672 · Henley Intl. · Oct 1991
DYNEX IIIB, MODEL 89002026
K913594 · Medtronic Vascular · Aug 1991
SX90 (TM),MODEL 4800S
K912348 · Medical Devices, Inc. · Jun 1991
ELECTRO-NEVE STIMULATOR TENS MODEL BIOMED PLUS/A
K905230 · Biomedical Life Systems, Inc. · Jun 1991
ELECTRO-NERVE STIMULATOR TENS MODEL SYSTEMS 2000/A
K905377 · Biomedical Life Systems, Inc. · Jun 1991
ELECTRO-NERVE STIMULATOR TENS MODEL BIOMED 2000/A
K905570 · Biomedical Life Systems, Inc. · Jun 1991